PMID: 6400709Sep 1, 1983Paper

A new approach to the treatment of nocturnal hypoglycemia using alpha-glucosidase inhibition

Diabetes Care
D K McCullochR B Tattersall

Abstract

Nocturnal hypoglycemia is common in the diabetic patient on twice-daily regular and intermediate (NPH or lente) insulin regimens because intermediate-acting insulins before the main evening meal produce "unopposed" free insulin peaks around 0300 h, food absorption having been completed much earlier. Fourteen insulin-dependent diabetic patients were treated for 6 wk with the alpha-glucosidase inhibitor, acarbose, in a double-blind crossover study to see whether the drug would delay absorption of the evening meal sufficiently to correct the mismatch and prevent nocturnal hypoglycemia. On 200 mg acarbose (six patients), inhibition of carbohydrate digestion was so profound as to lead to midevening hypoglycemia with severe flatulence and abdominal colic. With a smaller dose of 100 mg before the evening meal (eight patients) there was a significant reduction in MAGE and MBG coupled with a clinically significant reduction in midevening and nocturnal hypoglycemic reactions. Alpha-glucosidase inhibition therefore provides a promising new approach to the problem of nocturnal hypoglycemia although a preparation that is safe for long-term clinical use remains to be found.

Citations

Jan 1, 1988·European Journal of Clinical Pharmacology·D R BuchananB F Clarke
Jan 1, 1993·Applied Biochemistry and Biotechnology·J M WalkerS J Kellam
Feb 8, 2008·Archives of Pharmacal Research·Wanchai PluempanupatWarinthorn Chavasiri
Oct 6, 1997·Endocrinology and Metabolism Clinics of North America·H E Lebovitz
Nov 26, 2003·Clinics in Podiatric Medicine and Surgery·James BerneneGary Peter Jolly
Oct 19, 2001·Diabetic Medicine : a Journal of the British Diabetic Association·R Rabasa-LhoretJ L Chiasson
Jan 20, 2010·Clinical and Experimental Pharmacology & Physiology·Yu-Qian BaoWei-Ping Jia
Oct 1, 1993·Diabetic Medicine : a Journal of the British Diabetic Association·R Tattersall
Aug 5, 2009·Chemical & Pharmaceutical Bulletin·Huifang WangNing Tang
May 19, 2010·International Journal of Molecular Sciences·Jun XuYuqiang Wang
May 2, 2014·European Journal of Medicinal Chemistry·Farukh JabeenAlan R Katritzky
Feb 20, 2016·Bioorganic Chemistry·Muhammad TahaKhalid Mohammed Khan
Nov 30, 2010·Best Practice & Research. Clinical Endocrinology & Metabolism·Kamila Jauch-Chara, Bernd Schultes
Nov 11, 2015·Bioorganic & Medicinal Chemistry·Kulsoom JavaidM Iqbal Choudhary
Oct 25, 2011·Phytotherapy Research : PTR·Toshiyuki Takahashi, Mitsuo Miyazawa
Feb 4, 2011·Archiv der Pharmazie·Xuesen HuLin Ma
May 6, 2004·Bioorganic & Medicinal Chemistry Letters·Sirichai AdisakwattanaSirintorn Yibchok-anun
Sep 1, 1984·Diabetic Medicine : a Journal of the British Diabetic Association·D K McCulloch, R B Tattersall
Jan 1, 1988·Diabetic Medicine : a Journal of the British Diabetic Association·A R Scott, R B Tattersall
Jan 7, 1988·Diabetes Research and Clinical Practice·M Serrano-RiosI Hillebrand
Jul 18, 2015·Bioorganic & Medicinal Chemistry·Muhammad TahaKhalid Mohammed Khan
Oct 17, 2013·Diabetes Research and Clinical Practice·Simona FrontoniAntonio Ceriello
Jan 13, 2004·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Kate V Allen, Brian M Frier
Mar 16, 2004·Pediatric Diabetes·Krystyna A Matyka
Oct 1, 1986·Genitourinary Medicine·K C Mohanty, C S Scott
Nov 1, 1996·The Annals of Pharmacotherapy·L K CampbellR K Campbell
Aug 1, 1994·European Journal of Clinical Investigation·P J Lefebvre, A J Scheen
Sep 14, 2021·Journal of Biomolecular Structure & Dynamics·Waqas JamilSyed Adnan Ali Shah

❮ Previous
Next ❯

Related Concepts

Related Feeds

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.